PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25921F0086OPTION YEAR 1 exercise on ANNUAL — Ino Therapeutics LLC

Ino Therapeutics LLC holds $2.5M across 84 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 5 related awards under parent V797D60737. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Nov 30, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Network Contract Office 19 (36C259)

Awarding office

Ino Therapeutics LLC

Recipient

Nov 30, 2025

PoP end

$325K

Obligated

$1.3M

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ino Therapeutics LLC — $90

Contract facts

Federal

Contract number36C25921F0086

Also listed as36C259-21-F-0086

Also listed asV797D60737-36C25921F0086

AgencyNetwork Contract Office 19 (36C259)

Awarding officeNetwork Contract Office 19 (36C259)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentIno Therapeutics LLC

CAGE1PVS3

UEIXXQHL619FUN6

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVV797D60737

Place of performanceHAMPTON NJ

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startDec 1, 2020

PoP end (current)Nov 30, 2025

PoP end (w/ options)Nov 30, 2026

Obligated$325K

Current value$1.2M

Potential value$1.3M

OPTION YEAR 1 EXERCISE ON ANNUAL INHALED NITRIC OXIDE THERAPY GAS (INOTHERAPY) FOR OKC is a federal award for Network Contract Office 19 (36C259) held by Ino Therapeutics LLC. Estimated value $1.3M ($325K obligated). Current period of performance ends Nov 30, 2025 (potential Nov 30, 2026). Last award drew 1 bidder. Place of performance: HAMPTON NJ.

OPTION YEAR 1 EXERCISE ON ANNUAL INHALED NITRIC OXIDE THERAPY GAS (INOTHERAPY) FOR OKC

Recompete timing

Public

● Past PoP end (264 days ago)

Current PoP ended Nov 30, 2025 (264 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Ino Therapeutics LLC — $2.5M obligated across 84 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($2.5M) · all agencies

Department of Defense (DOD)$1.9M · 76%Department of Veterans Affairs (VA)$654K · 26%

Open full company profile →

Related awards

Same parent · incumbent

W81K0026FA029

INHALED NITRIC OXIDE

$158K

Dec 31, 2026

75N90024F00080

INO THERAPEUTICS INC:1107599 [26-001138]

$115K

Feb 28, 2027

36C25022F0432

EXERCISING OY1 THE HOURLY RATE IS CHANGING FROM $49.58 PER HOUR TO $38.91 PER HOUR BEGINNI…

$293K

Apr 26, 2027

36C24723F0049

INO THERAPUETIC

$207K

Sep 30, 2027

36C24223N0086

INOMAX NITRIC OXIDE GAS CYLINDER DELIVERY SERVICE

$149K

Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25921F0086?

36C25921F0086 (OPTION YEAR 1 exercise on ANNUAL) is a Network Contract Office 19 (36C259) award with a potential value of $1.3M, currently held by Ino Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C259-21-F-0086?

36C259-21-F-0086 is the dashed form of PIID 36C25921F0086 (OPTION YEAR 1 exercise on ANNUAL), held by Ino Therapeutics LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25921F0086?

Network Contract Office 19 (36C259) awarded 36C25921F0086 to Ino Therapeutics LLC (potential $1.3M).

Who is the incumbent on 36C25921F0086?

Ino Therapeutics LLC is the incumbent with $2.5M across 84 related awards in SCOUT’s public footprint. The current period of performance ends Nov 30, 2025.

When does Ino Therapeutics LLC’s 36C25921F0086 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 30, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Apr 7, 2026